首页|保山市HIV/AIDS患者合并HCV感染状况及影响因素分析

保山市HIV/AIDS患者合并HCV感染状况及影响因素分析

扫码查看
[目的]分析保山市HIV/AIDS患者合并HCV感染状况及影响因素,为HIV合并HCV感染防控提供科学依据.[方法]回顾性收集HIV/AIDS患者HCV抗体检测资料,将开展过HCV抗体检测的HIV/AIDS患者作为研究对象,收集人口学及行为学相关信息,采用χ2 检验做分类资料(构成比)的描述、Logistic回归作多因素分析.[结果]HIV/AIDS 患者合并 HCV 感染率为 6.4%,注射吸毒(OR=45.359,95%CI:19.171~107.322)、HIV/AIDS报告年龄 0~29 岁(OR=1.860,95%CI:1.123~3.080)、30~49 岁(OR=2.222,95%CI:1.413~3.492)、少数民族(OR=2.218,95%CI:1.601~3.073)、男性(OR=2.149,95%CI:1.610~2.870)、离异或丧偶(OR=1.643,95%CI:1.179~2.094)、未婚(OR=1.737,95%CI:1.282~2.352)、2010年及以前报告HIV(OR=1.505,95%CI:1.172~1.935)是HIV合并HCV感染的危险因素.[结论]保山市HIV合并HCV感染状况不容忽视,注射吸毒、HIV确诊年龄在 50 岁以下、男性、未婚、离异或丧偶、2010 年以前报告的HIV是合并HCV感染的高危因素.
Analysis of HIV/AIDS patients with hepatitis C virus(HCV)co-infection and its influencing factors in Baoshan
Objective To analyze HIV/AIDS patients with hepatitis C virus(HCV)co-infection and its influencing factors in Baoshan,and to provide the scientific basis for prevention and control of HIV/HCV co-infection.Methods The data of HCV antibody detection in HIV/AIDS patients were collected retrospectively.The HIV/AIDS patients who had been tested for HCV antibody were selected as the subjects,and the relevant demographic and behavioral information were collected.Chi-square test was used to describe the classification data(composition ratio),and logistic regression was used for multivariate analysis.Results The prevalence of HIV/HCV co-infection was 6.4%.Injection drug use(OR=45.359,95%CI:19.171-107.322),HIV/AIDS infections of aged 0 to 29(OR=1.860,95%CI:1.123-3.080),aged 30 to 49(OR=2.222,95%CI:1.413-3.492),ethnic minorities(OR=2.218,95%CI:1.601-3.073),male(OR=2.149,95%CI:1.610-2.870),divorced or widowed(OR=1.643,95%CI:1.179-2.094),unmarried(OR=1.737,95%CI:1.282-2.352),2010 and previous reports(OR=1.505,95%CI:1.172-1.935)were the risk factors of HIV/HCV co-infection.Conclusions HIV/HCV co-infection should not be ignored in Baoshan.Injection drug use,diagnosed HIV under the age of 50,male,unmarried,divorced or widowed,2010 and previous reports were the risk factors of HIV/HCV co-infection.

HIVHCVco-infectioninfluencing factors

董贤雅、杨晓娟、李红梅、李正旭、张腾、胡安艳

展开 >

保山市疾病预防控制中心,云南 保山 678000

保山中医药高等专科学校,云南 保山 678000

昆明医科大学公共卫生学院,云南 昆明 650500

人类免疫缺陷病毒 丙型肝炎病毒 合并感染 影响因素

2025

卫生软科学
中国卫生经济学会,云南省卫生厅

卫生软科学

影响因子:0.655
ISSN:1003-2800
年,卷(期):2025.39(1)